enVVeno Medical NVNO Cash Flow Statement (2017-2026)

NASDAQ NVNO
$6.17 -0.40 (-6.09%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

enVVeno Medical Quarterly Cash Flow Statement

Periods 38 quarters
Latest Sep 2026

enVVeno Medical reported cash from operations of -$3.18M and free cash flow of -$3.18M for the quarter ended Sep 2026, up 27.6% year over year. This cash flow statement covers 38 quarters of results from Jun 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-8.99M-5.33M-7.06M-6.10M-6.18M-6.39M-6.47M-5.00M-5.65M-4.99M-4.96M-5.64M-6.23M-4.50M-6.69M-4.54M-3.74M-3.85M-3.60M-4.37M
Depreciation and DepletionDep. & Depletion
0.06M0.10M0.10M0.10M0.10M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.05M0.05M0.05M0.05M0.05M0.05M0.06M0.06M0.06M0.06M0.05M0.04M0.04M0.04M0.03M0.03M0.03M0.03M-0.06M0.02M
Share-based CompensationStock Comp.
5.34M2.24M2.30M2.21M2.24M1.79M1.16M1.10M1.14M1.12M1.01M1.00M1.02M0.65M1.44M0.69M0.64M0.47M0.40M0.41M
Gains from Sales and DivestituresGains Divest
0.00M
Gains from Investment SecuritiesGains Investment
-0.11M-0.02M0.18M0.28M0.13M0.16M-0.10M0.04M0.05M0.01M-0.12M-0.20M0.10M0.04M-0.09M-0.04M0.02M0.02M
Other non-cash itemsOther Non-Cash
-0.24M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.08M0.08M0.10M0.09M0.09M0.09M0.09M0.09M
Non-cash ItemsNon-Cash Items
5.89M2.01M3.10M1.61M2.32M1.28M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
Change in Account PayablesChange Payables
0.17M0.00M0.48M-0.53M0.15M-0.27M0.92M
Change in Accrued ExpensesChange Accrued Exp.
0.34M-0.31M0.06M-0.04M0.13M-0.37M0.21M0.64M-0.67M0.11M0.20M0.53M-0.14M-0.44M1.35M-0.52M-0.38M0.02M-0.26M0.70M
Change in Other Operating AssetsOther Assets Change
0.00M0.14M0.01M-0.08M0.04M0.20M-0.04M-0.21M0.16M0.20M-0.09M-0.04M-0.08M0.09M0.07M-0.06M0.04M-0.05M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.08M-0.07M-0.07M-0.07M-0.07M-0.08M-0.08M-0.08M-0.08M-0.09M-0.08M-0.09M-0.08M-0.09M-0.10M-0.09M-0.09M-0.10M-0.10M-0.10M
Other Working Capital ChangesOther WC Changes
-0.08M-0.07M-0.07M-0.21M-0.08M0.00M-0.12M-0.28M-0.03M0.12M-0.25M-0.29M0.01M-0.04M-0.02M-0.18M-0.16M-0.04M-0.14M-0.05M
Cash from OperationsCash from Ops.
-3.10M-3.32M-3.96M-4.48M-3.86M-5.11M-4.56M-4.21M-4.97M-3.55M-3.91M-4.28M-5.11M-4.02M-3.72M-4.39M-3.44M-3.24M-3.55M-3.18M
Investing Activities
Capital ExpendituresCapex
0.07M0.07M0.02M0.01M0.01M0.01M0.02M0.00M0.00M0.01M0.01M0.01M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-0.07M-0.07M-0.02M-0.01M-0.01M-0.01M-0.02M0.00M0.00M-0.01M-0.01M-0.01M0.00M
Purchase of InvestmentsInvestments Purchased
3.93M5.91M8.63M6.47M9.18M32.24M15.14M9.93M8.35M22.15M8.87M7.93M9.90M19.32M22.24M18.57M15.84M
Sale and Maturity of InvestmentsInvestments Sold
11.44M11.46M13.50M13.63M10.10M17.34M13.92M14.58M11.10M14.08M10.76M13.55M23.50M25.01M22.24M18.58M
Other Investing Activities (as filed)Other investing (as filed)
Cash from Investing ActivitiesCash from Investing
-0.07M-0.07M-38.31M-1.69M5.52M2.83M7.00M4.45M-22.14M2.20M3.97M6.22M-11.06M5.20M2.82M3.65M4.18M2.77M3.67M2.74M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
Net Long-Term Debt Issued (Repaid)Net LT Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.01M0.05M13.59M0.19M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
0.01M0.05M13.59M0.19M
Net Equity Issued and RepurchasedNet Equity Issued
0.01M0.05M13.59M0.19M
Cash from Financing ActivitiesCash from Financing
0.00M0.05M13.59M0.78M0.19M
Additional items
Change in Cash
-3.17M-3.39M-42.27M-6.18M1.66M-2.28M2.44M0.23M-1.33M-1.31M0.07M15.54M-16.16M1.18M-0.89M-0.50M1.52M-0.47M0.24M-0.26M
Ending Cash Balance
54.73M51.34M9.07M2.90M4.56M2.27M4.71M4.95M3.62M2.31M2.38M17.92M1.75M2.94M2.04M1.54M3.07M2.60M2.84M2.59M
Free Cash FlowFCF
-3.17M-3.39M-3.98M-4.50M-3.87M-5.11M-4.58M-4.22M-4.98M-3.56M-3.92M-4.29M-5.11M-4.02M-3.72M-4.39M-3.44M-3.24M-3.55M-3.18M
Net Cash FlowNCF
-3.17M-3.39M-42.27M-6.18M1.66M-2.28M2.44M0.23M-27.12M-1.31M0.07M15.54M-16.16M1.18M-0.89M-0.74M1.52M-0.47M0.12M-0.26M
Interest Paid
0.01M0.04M0.03M0.06M0.05M0.04M

enVVeno Medical Cash Flow Statement API

Pull enVVeno Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NVNO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY